Galectin‐3: an emerging biomarker in stroke and cerebrovascular diseases

Publisher： John Wiley & Sons Inc

E-ISSN： 1468-1331|25|2|238-246

ISSN： 1351-5101

Source： EUROPEAN JOURNAL OF NEUROLOGY, Vol.25, Iss.2, 2018-02, pp. : 238-246

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Galectin-3 as a Novel Biomarker for Chagas Cardiomyopathy

By  

Cardiology, Vol. 136, Iss. 1, 2016-08 ,pp. : 33-39

Karger

Access to resources Recommend Favorite

The Emerging Role of Complement C3 as A Biomarker of Insulin Resistance and Cardiometabolic Diseases: Preclinical and Clinical Evidence

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 1, 2018-01 ,pp. : 61-68

Bentham Science Publishers

Access to resources Recommend Favorite

Galectin‐7 in the stratum corneum: a biomarker of the skin barrier function

By  

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Vol. 38, Iss. 5, 2016-10 ,pp. : 487-495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cerebrovascular Ultrasonography for Selecting Patients for Stroke Intervention

By  

Recent Patents on CNS Drug Discovery, Vol. 8, Iss. 3, 2013-01 ,pp. : 205-219

Bentham Science Publishers

Access to resources Recommend Favorite

Galectin-3 and Regulation of Cell Function

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 2, 2005-04 ,pp. : 83-96

Karger

Access to resources Recommend Favorite